Silverback Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $1.7M | 158k | 10.55 |
| 2024-09-30 | $1.6M | 112k | 14.49 |
| 2024-06-30 | $328k | 39k | 8.51 |
| 2024-03-31 | $306k | 30k | 10.24 |
| 2023-12-31 | $222k | 40k | 5.49 |
| 2023-09-30 | $67k | 18k | 3.75 |
| 2023-06-30 | $138k | 21k | 6.74 |
| 2023-03-31 | $232k | 36k | 6.48 |
| 2022-12-31 | $177k | 21k | 8.51 |
| 2022-09-30 | $106k | 20k | 5.30 |
| 2022-06-30 | $89k | 21k | 4.26 |
| 2022-03-31 | $60k | 17k | 3.51 |